Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Diabetes

PUBLISHER: Grand View Research | PRODUCT CODE: 2067540

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2067540

Diabetes Devices Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Diabetes Devices Market Summary

The global diabetes devices market sizewas estimated at USD 45.85 billion in 2025 and is projected to reach USD 101.66 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. The market is primarily driven by growing prevalence of diabetes, advanced technology, the growing usage of insulin delivery devices, and the rise in obesity rates.

Major manufacturers are concentrating on technological innovation and the creation of advanced products to secure a significant portion of the diabetes care devices market. For instance, in January 2025, Dexcom announced the expansion of its AI-enabled continuous glucose monitoring ecosystem through new integrations with digital health and automated insulin delivery platforms to improve personalized diabetes management and remote patient monitoring capabilities. The development strengthened the company's connected diabetes care portfolio and is expected to accelerate the adoption of advanced CGM and automated insulin delivery technologies globally, thereby supporting the diabetes management devices market growth.

The increasing prevalence of diabetes worldwide has created a strong demand for diabetes devices over the forecast period. According to the latest 11th Edition of the International Diabetes Federation (IDF) Diabetes Atlas published in 2025, approximately 589 million adults aged 20-79 years are currently living with diabetes globally, representing nearly 1 in 9 adults worldwide. The organization further projects that the number of adults living with diabetes likely to increase to nearly 853 million by 2050, reflecting the rapidly growing global disease burden. In addition, more than 40% of diabetic individuals remain undiagnosed, increasing the risk of severe complications and driving the need for continuous glucose monitoring systems, insulin delivery devices, and early diagnostic technologies. Furthermore, over 81% of people with diabetes live in low- and middle-income countries, highlighting significant growth opportunities for affordable and connected diabetes care solutions across emerging markets. These rising prevalence trends, coupled with increasing obesity rates, sedentary lifestyles, and aging populations, are expected to significantly support the growth of the diabetes devices market during the forecast period.

The increasing demand in the diabetes care drugs devices market is largely driven by the growing need to reduce diabetes-related complications, prevent prolonged hospital stays, and lower mortality rates among diabetic patients. Diabetes devices such as continuous glucose monitors, insulin delivery systems, and blood glucose monitoring devices enable real-time tracking and effective management of blood sugar levels, helping patients take timely action to control their condition. These technologies support better treatment adherence and allow healthcare providers to make faster adjustments to therapy plans, resulting in improved disease management and patient outcomes. In addition, the rising adoption of advanced diabetes care solutions is improving the overall quality of life for individuals living with diabetes by minimizing the risk of severe health complications. Consequently, the expanding use of these devices continues to strengthen the growth of the diabetes care drugs devices market by enhancing patient care, improving clinical efficiency, and supporting long-term disease management.

The market is growing due to the increasing prevalence of diabetes resulting from aging, obesity, and unhealthy lifestyle choices. Obesity is a significant factor leading to diabetes. According to the latest data published by the World Health Organization in 2025, more than 2.5 billion adults aged 18 years and older were overweight in 2022, including over 890 million adults living with obesity. In addition, the worldwide prevalence of obesity has more than doubled since 1990, with approximately 16% of the global adult population classified as obese. Furthermore, the World Obesity Federation reported in its 2025 World Obesity Atlas that the number of adults living with obesity is projected to increase nearly 1.53 billion by 2035. Rising obesity levels are significantly increasing the risk of Type 2 diabetes, cardiovascular diseases, and metabolic disorders, thereby driving the demand for continuous glucose monitoring systems, insulin delivery devices, and other advanced diabetes management technologies during the forecast period.

The presence of a substantial elderly population, affordable healthcare options, cost-effective labor, and less rigorous regulatory frameworks are driving diabetic device manufacturers to expand. They are prioritizing exploiting opportunities in emerging markets to increase their market dominance. The demand for diabetes devices is also rising due to technological advancements, including introducing of advanced insulin pumps and pens. Significant companies are concentrating on technological advancements and creating advanced products to secure a significant portion of the market. For instance, in April 2025, Medtronic announced the U.S. FDA submission for its interoperable MiniMed 780G insulin pump designed for integration with Abbott's advanced CGM platform. The development is expected to accelerate the adoption of connected diabetes management ecosystems by improving interoperability, enhancing glucose control automation, and expanding access to advanced insulin delivery technologies across global markets.

Global Diabetes Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global diabetes devices market report based on type, distribution channel, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • BGM Devices
    • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
    • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
  • Insulin Delivery Devices
    • Pens
    • Pum
    • Syringes
    • Jet Injectors
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Homecare
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-873-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Distribution Channel
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Distribution Channel outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Diabetes Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Diabetes Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Diabetes Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Diabetes Devices Market: Type Movement Analysis
  • 4.3. Diabetes Devices Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. BGM Devices
    • 4.5.1. BGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Self Monitoring Devices
      • 4.5.2.1. Self Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.2. Blood Glucose Meter
        • 4.5.2.2.1. Blood Glucose Meter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.3. Testing Strips
        • 4.5.2.3.1. Testing Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.4. Lancets
        • 4.5.2.4.1. Lancets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Continuous Glucose Monitoring Devices
      • 4.5.3.1. Continous Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.2. Sensors
        • 4.5.3.2.1. Sensors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.3. Transmitter
        • 4.5.3.3.1. Transmitters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.4. Receiver
        • 4.5.3.4.1. Receivers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Insulin Delivery Devices
    • 4.6.1. Insulin Delivery Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Pens
      • 4.6.2.1. Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Pumps
      • 4.6.3.1. Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Syringes
      • 4.6.4.1. Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Jet Injector
      • 4.6.5.1. Jet Injector Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Diabetes Devices Market: Distribution Channel Movement Analysis
  • 5.3. Diabetes Devices Market by Distribution Channel Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Retail Pharmacies
    • 5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Diabetes Clinics/ Centers
    • 5.7.1. Diabetes Clinics/ Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Online Pharmacies
    • 5.8.1. Online PharmaciesMarket Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Diabetes Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Diabetes Devices Market: End Use Movement Analysis
  • 6.3. Diabetes Devices Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Dignostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Homecare
    • 6.7.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Diabetes Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Diabetes Devices Market Movement Analysis
  • 7.3. Diabetes Devices Market: Regional Estimates & Trend Analysis by Type & Distribution Channel
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Europe
    • 7.5.5. Europe Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. UK
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. UK Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Germany
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Germany Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. France
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. France Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Italy
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. Italy Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Spain
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Spain Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Denmark
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Denmark Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Sweden
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Sweden Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Norway
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Norway Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Mexico Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Argentina Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic plc
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Abbott Laboratories
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. F.Hoffmann-La-Ltd.
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Bayer AG
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Lifescan, Inc.
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. B Braun Melsungen AG
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Lifescan, Inc.
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Dexcom Inc.
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Insulet Corporation
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Ypsomed Holdings
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Companion Medical
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Sanofi
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Valeritas Holding Inc.
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Novo Nordisk
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Arkray, Inc.
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product Benchmarking
      • 8.2.15.4. Strategic Initiatives
Show more
Product Code: 978-1-68038-873-2

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 4. Global diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 5. Global Diabetes Devices market, by end use, 2021 - 2033 (USD Million)
  • Table 6. North America diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 8. North America diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9. North America diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 10. U.S. diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 11. U.S. diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 12. U.S. diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 13. Canada diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 14. Canada diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15. Canada diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 18. Europe diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19. Europe diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20. UK diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 21. UK diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22. UK diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Germany diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 24. Germany diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 25. Germany diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26. France diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 27. France diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28. France diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Italy diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 30. Italy diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 31. Italy diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 32. Denmark diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 33. Denmark diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34. Denmark diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35. Sweden diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 36. Sweden diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37. Sweden diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 38. Norway diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 39. Norway diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40. Norway diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41. Asia Pacific diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 42. Asia Pacific diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 43. Asia Pacific diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44. Asia Pacific diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 45. Japan diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 46. Japan diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47. Japan diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48. China diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 49. China diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 50. China diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 51. India diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 52. India diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 53. India diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Australia diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 55. Australia diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56. Australia diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57. South Korea diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 58. South Korea diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59. South Korea diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 60. Thailand diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 61. Thailand diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 62. Thailand diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 63. Latin America diabetes devices market, by Country, 2021 - 2033 (USD Million)
  • Table 64. Latin America diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 65. Latin America diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66. Latin America diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 67. Brazil diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 68. Brazil diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 69. Brazil diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 70. Mexico diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 71. Mexico diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 72. Mexico diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 73. Argentina diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 74. Argentina diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 75. Argentina diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 76. Middle East & Africa diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 77. Middle East & Africa diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 80. South Africa diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 81. South Africa diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 82. South Africa diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 83. Saudi Arabia diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 84. Saudi Arabia diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85. Saudi Arabia diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 86. UAE diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 87. UAE diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 88. UAE diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 89. Kuwait diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 90. Kuwait diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 91. Kuwait diabetes devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Diabetes devices market: Market outlook
  • Fig. 14 Diabetes devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Diabetes devices market driver impact
  • Fig. 20 Diabetes devices market restraint impact
  • Fig. 21 Diabetes devices market: type movement analysis
  • Fig. 22 Diabetes devices market: type outlook and key takeaways
  • Fig. 23 Blood glucose monitoring devices market estimates and forecast, 2021 - 2033
  • Fig. 24 Self-monitoring devices market estimates and forecast, 2021 - 2033
  • Fig. 25 Blood glucose meters market estimates and forecast, 2021 - 2033
  • Fig. 26 Testing strips market estimates and forecast, 2021 - 2033
  • Fig. 27 Lancets market estimates and forecast, 2021 - 2033
  • Fig. 28 Continuous glucose monitoring devices market estimates and forecast, 2021 - 2033
  • Fig. 29 Sensors market estimates and forecast, 2021 - 2033
  • Fig. 30 Transmitters market estimates and forecast, 2021 - 2033
  • Fig. 31 Receivers market estimates and forecast, 2021 - 2033
  • Fig. 32 Insulin delivery devices market estimates and forecast, 2021 - 2033
  • Fig. 33 Pumps market estimates and forecast, 2021 - 2033
  • Fig. 34 Pens market estimates and forecast, 2021 - 2033
  • Fig. 35 Syringes market estimates and forecast, 2021 - 2033
  • Fig. 36 Jet injectors market estimates and forecast, 2021 - 2033
  • Fig. 37 Diabetes devices market: distribution channel movement analysis
  • Fig. 38 Diabetes devices market: distribution channel outlook and key takeaways
  • Fig. 39 Hospital pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 40 Retail pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 41 Diabetes clinics/centers market estimates and forecast, 2021 - 2033
  • Fig. 42 Online pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecast, 2021 - 2033
  • Fig. 44 Diabetes devices market: end use movement analysis
  • Fig. 45 Diabetes devices market: end use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecast, 2021 - 2033
  • Fig. 47 Diagnostic centers market estimates and forecast, 2021 - 2033
  • Fig. 48 Homecare market estimates and forecast, 2021 - 2033
  • Fig. 49 Global Diabetes devices market: regional movement analysis
  • Fig. 50 Global Diabetes devices market: regional outlook and key takeaways
  • Fig. 51 North America
  • Fig. 52 North America market estimates and forecast, 2021 - 2033
  • Fig. 53 US
  • Fig. 54 US market estimates and forecast, 2021 - 2033
  • Fig. 55 Canada
  • Fig. 56 Canada market estimates and forecast, 2021 - 2033
  • Fig. 57 Europe
  • Fig. 58 Europe market estimates and forecast, 2021 - 2033
  • Fig. 59 UK
  • Fig. 60 UK market estimates and forecast, 2021 - 2033
  • Fig. 61 Germany
  • Fig. 62 Germany market estimates and forecast, 2021 - 2033
  • Fig. 63 France
  • Fig. 64 France market estimates and forecast, 2021 - 2033
  • Fig. 65 Italy
  • Fig. 66 Italy market estimates and forecast, 2021 - 2033
  • Fig. 67 Spain
  • Fig. 68 Spain market estimates and forecast, 2021 - 2033
  • Fig. 69 Denmark
  • Fig. 70 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 71 Sweden
  • Fig. 72 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 73 Norway
  • Fig. 74 Norway market estimates and forecast, 2021 - 2033
  • Fig. 75 Asia Pacific
  • Fig. 76 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 77 Japan
  • Fig. 78 Japan market estimates and forecast, 2021 - 2033
  • Fig. 79 China
  • Fig. 80 China market estimates and forecast, 2021 - 2033
  • Fig. 81 India
  • Fig. 82 India market estimates and forecast, 2021 - 2033
  • Fig. 83 South Korea
  • Fig. 84 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 85 Thailand
  • Fig. 86 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 87 Australia
  • Fig. 88 Australia market estimates and forecast, 2021 - 2033
  • Fig. 89 Latin America
  • Fig. 90 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 91 Brazil
  • Fig. 92 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 93 Mexico
  • Fig. 94 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 95 Argentina
  • Fig. 96 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 97 Middle East and Africa
  • Fig. 98 Middle East and Africa market estimates and forecast, 2021 - 2033
  • Fig. 99 Saudi Arabia
  • Fig. 100 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 101 South Africa
  • Fig. 102 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 103 UAE
  • Fig. 104 UAE market estimates and forecast, 2021 - 2033
  • Fig. 105 Kuwait
  • Fig. 106 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 107 Participant categorization - Diabetes devices market
  • Fig. 108 Market share of key market players - Diabetes devices market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!